Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis
Open Access
- 27 June 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 46 (1) , 275-277
- https://doi.org/10.1002/hep.21807
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Biosynthesis of Selenocysteine on Its tRNA in EukaryotesPLoS Biology, 2006
- RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaeaProceedings of the National Academy of Sciences, 2006
- Human selenoproteins at a glanceCellular and Molecular Life Sciences, 2005
- Autoantibodies and Autoantigens in Autoimmune HepatitisSeminars in Liver Disease, 2002
- Fine specificity of autoantibodies to soluble liver antigen and liver/pancreasHepatology, 2002
- Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitisThe Lancet, 2000
- Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitisHepatology, 1997
- Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion.Proceedings of the National Academy of Sciences, 1992
- Patients With Type Ii Autoimmune Hepatitis Express Functionally Intact Cytochrome P–450 Db1 That Is Inhibited by Lkm–1 Autoantibodies In Vitro But Not In VivoHepatology, 1990
- CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGENThe Lancet, 1987